IL114852A - Pharmaceutically stable preparation of oxaliplatinum - Google Patents

Pharmaceutically stable preparation of oxaliplatinum

Info

Publication number: IL114852A
Authority: IL; Israel
Prior art keywords: oxaliplatinum; pct; pharmaceutically stable; stable preparation; preparation
Prior art date: 1994-08-08

Application number

IL11485295A

Other languages

English (en)

Other versions

IL114852A0 (en

Inventor

Rolland-Yves Mauvernay

Houssam Ibrahim

Original Assignee

Debiopharm Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-08

Filing date

1995-08-07

Publication date

2000-02-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50845249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL114852(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-08-07 Application filed by Debiopharm Sa filed Critical Debiopharm Sa

1995-12-08 Publication of IL114852A0 publication Critical patent/IL114852A0/xx

2000-02-29 Publication of IL114852A publication Critical patent/IL114852A/xx

Links

239000007864 aqueous solution Substances 0.000 abstract 1
238000007911 parenteral administration Methods 0.000 abstract 1
239000000243 solution Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

IL11485295A 1994-08-08 1995-08-07 Pharmaceutically stable preparation of oxaliplatinum IL114852A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH246294		1994-08-08

Publications (2)

Publication Number	Publication Date
IL114852A0 IL114852A0 (en)	1995-12-08
IL114852A true IL114852A (en)	2000-02-29

Family

ID=50845249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11485295A IL114852A (en)	1994-08-08	1995-08-07	Pharmaceutically stable preparation of oxaliplatinum

Country Status (17)

Country	Link
US (1)	US5716988A (de)
EP (1)	EP0774963B1 (de)
JP (1)	JP3547755B2 (de)
KR (1)	KR100365171B1 (de)
CN (1)	CN1138541C (de)
AT (1)	ATE197249T1 (de)
AU (2)	AU2989695A (de)
BR (1)	BR9508554A (de)
CA (1)	CA2196922C (de)
CZ (1)	CZ286714B6 (de)
DE (1)	DE69519300T2 (de)
DK (1)	DK0774963T3 (de)
ES (1)	ES2152412T3 (de)
IL (1)	IL114852A (de)
RU (1)	RU2148400C1 (de)
UA (1)	UA42779C2 (de)
WO (1)	WO1996004904A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2989695A (en)	1994-08-08	2000-03-07	Debiopharm S.A.	Pharmaceutically stable oxaliplatinum preparation
GB9804013D0 (en) *	1998-02-25	1998-04-22	Sanofi Sa	Formulations
DE69901725T2 (de) *	1998-10-14	2003-01-30	Debiopharm S.A., Lausanne	Verpackung eines oxaliplatinhaltigen arzneimittels
GB9904386D0 (en) *	1999-02-25	1999-04-21	Pharmacia & Upjohn Spa	Antitumour synergistic composition
CA2382389C (fr) *	1999-08-30	2010-06-29	Debiopharm S.A.	Preparation pharmaceutique stable d'oxaliplatine pour administration par voie parenterale
US7070796B1 (en)	1999-08-30	2006-07-04	Debiopharm S.A.	Pharmaceutically stable oxaliplatinum preparation for parenteral administration
US7012072B2 (en)	2000-12-12	2006-03-14	Debiopharm S.A.	Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
EP1368022B1 (de)	2001-03-02	2007-06-20	Debiopharm S.A.	Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens
US20140186361A1 (en)	2012-09-07	2014-07-03	Coherus Biosciences, Inc.	Stable Aqueous Formulations of Adalimumab
EP1404689A1 (de) *	2001-07-02	2004-04-07	Debiopharm S.A.	Aktive oxiplatinverbindung mit sehr niedrigem oxalsaüregehalt
TWI315982B (en)	2001-07-19	2009-10-21	Novartis Ag	Combinations comprising epothilones and pharmaceutical uses thereof
US6476068B1 (en)	2001-12-06	2002-11-05	Pharmacia Italia, S.P.A.	Platinum derivative pharmaceutical formulations
CA2388352A1 (en) *	2002-05-31	2003-11-30	Voiceage Corporation	A method and device for frequency-selective pitch enhancement of synthesized speed
US20040022842A1 (en) *	2002-06-03	2004-02-05	Mebiopharm Co., Ltd.	Liposome preparations containing oxaliplatin
CA2537170A1 (en) *	2003-08-28	2005-03-10	Mayne Pharma Pty Ltd	Acid containing oxaliplatin formulations
CA2547275A1 (en)	2003-11-25	2005-06-09	Platco Technologies (Proprietary) Limited	Platinum(ii) complexes, preparation and use
CN100471493C (zh) *	2003-12-17	2009-03-25	梅比欧法姆股份有限公司	含有奥沙利铂的脂质体制剂
NZ551637A (en) *	2004-06-09	2010-05-28	Taiho Pharmaceutical Co Ltd	Antitumor effect fortifier, antitumor agent and method of therapy for cancer
PL1789427T3 (pl)	2004-09-01	2009-10-30	Platco Tech Proprietary Limited	Otrzymywanie kompleksów platyny (II)
US20060063720A1 (en) *	2004-09-22	2006-03-23	Edgar Schridde	Oxaliplatin solution concentrate
US20060063833A1 (en) *	2004-09-22	2006-03-23	Edgar Schridde	Ready-to-use oxaliplatin solutions
DE102004052877B4 (de) *	2004-11-02	2008-06-19	Ebewe Pharma Ges.M.B.H. Nfg.Kg	Stabile wässrige Formulierungen eines Platin-Derivats
JP2006248978A (ja)	2005-03-10	2006-09-21	Mebiopharm Co Ltd	新規なリポソーム製剤
WO2007029268A2 (en)	2005-09-05	2007-03-15	Dabur Pharma Limited	Stable oxaliplatin formulation
KR20080096682A (ko)	2006-01-30	2008-10-31	플라트코 테크놀로지스 (프로프라이어터리) 리미티드	백금(ⅱ) 착물의 제조법
EP2004175A4 (de) *	2006-03-16	2010-12-15	Bionumerik Pharmaceuticals Inc	Verbindungen und formulierungen zur verstärkung der wirkung gegen krebs und verfahren zu deren verwendung
JP2009536180A (ja)	2006-05-09	2009-10-08	ノバルティスアクチエンゲゼルシャフト	鉄キレート剤と抗新生物剤を含む組合せ剤およびそれらの使用
EA017864B1 (ru) *	2007-01-18	2013-03-29	Мерк Патент Гмбх	Специфическая терапия и лекарственное средство на основе интегриновых лигандов для лечения рака
US20090076139A1 (en) *	2007-09-19	2009-03-19	Protia, Llc	Deuterium-enriched oxalplatin
US20100267824A1 (en) *	2007-11-12	2010-10-21	Intas Pharmaceuticals Limited	Stable oxaliplatin composition for parenteral administration
DK2249825T3 (en)	2008-03-14	2016-01-11	Bionumerik Pharmaceuticals Inc	Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions
WO2009113989A1 (en)	2008-03-14	2009-09-17	Bionumerik Pharmaceuticals, Inc.	Compositions and methods of use of compounds to increase cancer patient survival time
MX348668B (es)	2009-09-21	2017-06-23	J W Pharmaceutical Corp *	Nanopartículas de oxaliplatin y método para prepararlas.
US20130096170A1 (en)	2011-10-14	2013-04-18	Hospira, Inc.	Methods of treating pediatric patients using dexmedetomidine
US8242158B1 (en) *	2012-01-04	2012-08-14	Hospira, Inc.	Dexmedetomidine premix formulation
AU2013202575B1 (en) *	2012-01-04	2013-05-16	Hospira, Inc.	Dexmedetomidine premix formulation
JP5314790B1 (ja) *	2012-07-09	2013-10-16	東和薬品株式会社	オキサリプラチン含有医薬組成物
WO2014025042A1 (ja)	2012-08-10	2014-02-13	大鵬薬品工業株式会社	安定なオキサリプラチン封入リポソーム水分散液及びその安定化方法
CN103690494B (zh) *	2013-11-29	2015-04-15	杭州华东医药集团新药研究院有限公司	一种低杂质含有奥沙利铂的组合物及其制备方法
BR112016030310A2 (pt)	2014-06-23	2017-08-22	Placon Therapeutics Inc	Compostos de platina, composições e seus usos
CA2990521C (en)	2015-07-07	2023-10-10	H. Lundbeck A/S	Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases
CN104940151A (zh) *	2015-07-23	2015-09-30	青岛蓝盛洋医药生物科技有限责任公司	一种抗癌药物奥沙利铂冻干粉针剂组合物
US11229702B1 (en)	2015-10-28	2022-01-25	Coherus Biosciences, Inc.	High concentration formulations of adalimumab
US11071782B2 (en)	2016-04-20	2021-07-27	Coherus Biosciences, Inc.	Method of filling a container with no headspace
US10987353B2 (en)	2016-05-04	2021-04-27	The Wistar Institute Of Anatomy And Biology	Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs
IL295973A (en)	2016-07-06	2022-10-01	H Lundbeck As	pde9 inhibitors for the treatment of peripheral diseases
HUE065158T2 (hu)	2017-05-26	2024-05-28	Cardurion Pharmaceuticals Inc	PDE9 gátlószereinek elõállítására és alkalmazására szolgáló eljárások
BR112020024019A2 (pt)	2018-05-25	2021-02-23	Imara Inc.	monoidrato e formas cristalinas de 6-[(3s,4s)-4-metil-1-(pirimidin-2-ilmetil)pirrolidin-3-il]-3-tetra-hidropiran-4-il-7h-imidazo[1,5-a]pirazin-8-ona
KR20250108770A (ko)	2018-08-31	2025-07-15	카듀리온 파마슈티칼스, 인크.	겸상 세포 질환의 치료를 위한 pde9 억제제

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6041077B2 (ja) *	1976-09-06	1985-09-13	喜徳喜谷	１，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
US4657927A (en) *	1978-05-04	1987-04-14	Research Corporation	Malonato platinum compounds
IL83380A (en) *	1987-07-30	1991-04-15	Teva Pharma	Stable aqueous cisplatin solutions
NL8901433A (nl) *	1989-06-06	1991-01-02	Pharmachemie Bv	Carboplatinpreparaat.
JPH04185601A (ja) *	1990-11-20	1992-07-02	Unitika Ltd	白金抗癌剤徐放性製剤
JP2673331B2 (ja)	1993-01-12	1997-11-05	田中貴金属工業株式会社	光学的に高純度なシス―オキザラート（トランス―１―１，２―シクロヘキサンジアミン）白金（▲ｉｉ▼）
AU5416394A (en) *	1992-11-24	1994-06-22	Debiopharm S.A.	Cisplatinum/oxaliplatinum combination
US5455270A (en) *	1993-08-11	1995-10-03	Bristol-Myers Squibb Co.	Stabilized solutions of platinum(II) antitumor agents
AU2989695A (en)	1994-08-08	2000-03-07	Debiopharm S.A.	Pharmaceutically stable oxaliplatinum preparation

1995
- 1995-08-07 AU AU29896/95A patent/AU2989695A/en not_active Abandoned
- 1995-08-07 BR BR9508554A patent/BR9508554A/pt not_active IP Right Cessation
- 1995-08-07 AT AT95925976T patent/ATE197249T1/de not_active IP Right Cessation
- 1995-08-07 ES ES95925976T patent/ES2152412T3/es not_active Expired - Lifetime
- 1995-08-07 DE DE69519300T patent/DE69519300T2/de not_active Expired - Lifetime
- 1995-08-07 US US08/776,240 patent/US5716988A/en not_active Expired - Lifetime
- 1995-08-07 JP JP50715996A patent/JP3547755B2/ja not_active Expired - Lifetime
- 1995-08-07 KR KR1019970700780A patent/KR100365171B1/ko not_active Ceased
- 1995-08-07 CZ CZ1997379A patent/CZ286714B6/cs not_active IP Right Cessation
- 1995-08-07 IL IL11485295A patent/IL114852A/xx not_active IP Right Cessation
- 1995-08-07 RU RU97104030A patent/RU2148400C1/ru not_active IP Right Cessation
- 1995-08-07 UA UA97010366A patent/UA42779C2/uk unknown
- 1995-08-07 CN CNB951944436A patent/CN1138541C/zh not_active Expired - Lifetime
- 1995-08-07 WO PCT/IB1995/000614 patent/WO1996004904A1/fr not_active Ceased
- 1995-08-07 CA CA002196922A patent/CA2196922C/fr not_active Expired - Lifetime
- 1995-08-07 DK DK95925976T patent/DK0774963T3/da active
- 1995-08-07 EP EP95925976A patent/EP0774963B1/de not_active Expired - Lifetime
1999
- 1999-03-31 AU AU22524/99A patent/AU731981B2/en not_active Expired

Also Published As

Publication number	Publication date
AU2989695A (en)	2000-03-07
EP0774963B1 (de)	2000-11-02
JP3547755B2 (ja)	2004-07-28
EP0774963A1 (de)	1997-05-28
CZ286714B6 (en)	2000-06-14
CZ37997A3 (en)	1997-06-11
KR100365171B1 (ko)	2003-02-19
IL114852A0 (en)	1995-12-08
BR9508554A (pt)	1997-11-25
AU2252499A (en)	2000-03-23
KR970704434A (ko)	1997-09-06
RU2148400C1 (ru)	2000-05-10
ATE197249T1 (de)	2000-11-15
CA2196922C (fr)	2004-06-01
UA42779C2 (uk)	2001-11-15
CN1138541C (zh)	2004-02-18
AU731981B2 (en)	2001-04-12
CN1154654A (zh)	1997-07-16
JPH10508289A (ja)	1998-08-18
US5716988A (en)	1998-02-10
CA2196922A1 (fr)	1996-02-22
DE69519300T2 (de)	2001-05-31
DK0774963T3 (da)	2001-01-29
WO1996004904A1 (fr)	1996-02-22
DE69519300D1 (de)	2000-12-07
ES2152412T3 (es)	2001-02-01

Legal Events

Date	Code	Title
2000-06-29	FF	Patent granted
2001-10-31	KB	Patent renewed
2005-11-20	KB	Patent renewed
2010-04-08	KB	Patent renewed
2013-07-31	KB	Patent renewed
2016-03-31	EXP	Patent expired

Publication	Publication Date	Title
IL114852A0 (en)	1995-12-08	A pharmaceutically stable preparation of oxaliplatinum
PL325825A1 (en)	1998-08-03	Microemulsion for use as a carrier for administering active compounds
IL150326A (en)	2005-06-19	Pediatric formula
MXPA02008654A (es)	2004-09-06	Formulaciones de ranolazina de liberacion prolongada.
RU94040387A (ru)	1996-10-20	Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
NO20054324L (no)	2001-04-30	Anvendelse av ranolazin og minst ett pH-avhengig bindemiddel for fremstilling av ranolazinpreparater med depotvirkning
IL82209A0 (en)	1987-10-30	Insulin preparation
ZA912793B (en)	1992-12-30	Pharmaceutical formulations
MY114389A (en)	2002-10-31	Aqueous risperidone formulations
WO2002019999A3 (en)	2003-03-27	Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant
GR3025742T3 (en)	1998-03-31	New pyrazine derivatives, their preparation and their use.
WO2000041504A3 (en)	2000-11-09	Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides
IL145187A0 (en)	2002-06-30	Echinocandin/carbohydrate complexes
ZA971134B (en)	1997-08-25	Multifunctional fat absorption and blood cholesterol reducing formulation.
DK1673074T3 (da)	2007-05-07	Flydende præparat, indeholdende tobramycin
EE04264B1 (et)	2004-04-15	Naatriumkloriidi kasutamine aine valmistamiseks kamptotetsiini derivaatide manustamisest tingitud gastrointestinaalsete kõrvaltoimete vähendamiseks
NZ507407A (en)	2002-08-28	Stable mitoxantrone solutions
CA2015632A1 (en)	1990-11-10	Stable solutions of rebeccamycin analog and preparations thereof
NZ334949A (en)	2000-12-22	Stabilised pharmaceutical composition of quinupristine and dalfopristine with methanesulphonic acid or hydrochloric acid
ZA988820B (en)	1999-04-06	Use of delta-aminolaevulinic acid for the preparation of a topical medicament for the integral diagnosis and/or therapy of tumours in hollow organs
PL350413A1 (en)	2002-12-02	Pharmaceutical effervescent formulation containing metamizol
Lin et al.	1997	Toxicity of a single oral dose of N-ethylphenylacetamide in rats
CA2120751A1 (en)	1993-04-15	Trimethoprim oral liquid
ES2125800A1 (es)	1999-03-01	Conjunto de infusion final.
ES2128966A1 (es)	1999-05-16	Composiciones farmaceuticas parenterales a base de calcitoninas sinteticas, de ph controlado, con bajo indice de dolor y buena estabilidad.